rs876657679
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PVS1PM2PP3_StrongPP5
The NM_017721.5(CC2D1A):c.748+1G>T variant causes a splice donor change. The variant allele was found at a frequency of 0.000000691 in 1,446,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017721.5 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CC2D1A | NM_017721.5 | c.748+1G>T | splice_donor_variant | ENST00000318003.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CC2D1A | ENST00000318003.11 | c.748+1G>T | splice_donor_variant | 1 | NM_017721.5 | P3 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome AF: 6.91e-7 AC: 1AN: 1446844Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 718292
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
Intellectual disability, autosomal recessive 3 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 26, 2019 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Pathogenic, no assertion criteria provided | clinical testing | Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City | Sep 26, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 25, 2024 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 29, 2022 | Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease and demonstrated complete skipping of exon 6, leading to a premature stop codon (Manzini et al., 2014); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25066123, 28454995, 31130284, 32552793) - |
Intellectual disability Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 15, 2015 | The c.748+1G>T variant in CC2D1A has been reported in 2 Saudi Arabian families w ith spectrum of neurodevelopmental phenotypes, including nonsyndromic intellectu al disability, language impairment, autism spectrum disorder and seizures (Manzi ni 2014). The variant segregated with disease in a reccessive manner in a total of 11 individuals from both families and was absent from large population studie s. This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and was shown to cause skipping of exon 6, resulting in complete loss of CC2D1A protein expression (Manzini 2014). In summary, this variant meets our criteria to be classified as pathogenic for nonsyndromic intellectual disability with or without seizures in an autosomal recessive manner (http://www.partners. org/personalizedmedicine/LMM) based upon segregation studies, absence from contr ols and functional studies. - |
Premature ovarian failure 19 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at